Long-term L-carnitine supplementation prevents development of li... ( A study will be published on March 2...)

Long-term L-carnitine supplementation prevents development of liver cancer

Date:3/24/2009

A study will be published on March 21, 2009 in World Journal of Gastroenterology addresses the question. A research group in King Saud University, Kingdom of Saudi Arabia investigated, for the first time, the role of carnitine, a naturally occurring compound that is synthesized mainly in the liver, during the development of hepatocarcinogenesis. Authors of the study reported that carnitine deficiency is a risk factor and should be viewed as a mechanism in hepatic carcinogenesis, and that long-term L-carnitine supplementation prevents the development of liver cancer. Therefore, carnitine supplementation alone or in combination with other natural chemopreventive compounds could be used to prevent, slow or reverse the occurrence of liver cancer.

Chemoprevention is defined as the use of naturally occurring and/or synthetic compounds in cancer therapy in which the occurrence of cancer can be entirely prevented, slowed or reversed. L-carnitine is a naturally occurring compound which is primarily located in mitochondria and possesses potential protective effects against many mitochondrial toxic agents. It is derived from two sources; endogenous synthesis, in the liver and kidney, and from exogenous dietary sources such as red meat and dairy products. L-carnitine is an essential cofactor for the translocation of long chain fatty acids from the cytoplasmic compartment into mitochondria, where beta-oxidation enzymes are located for ATP production. Despite the liver being the main organ responsible for endogenous synthesis of L-carnitine, we were unable to find any studies investigating the role of long-term endogenous carnitine depletion and/or carnitine deficiency during induction of hepatic carcinogenesis.

The research team by Professor Sayed-Ahmed from College of Pharmacy, King Saud University used an experimental model of hepatocarcinogenesis under conditions of carnitine depletion and carnitine supplementation.

In the carnitine-depl
'/>"/>

Contact: Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008
2. Studies show children can complete treatment for peanut allergies and achieve long-term tolerance
3. Global Leader in Information Technology Services and Business Solutions Signs Long-Term Agreement with PureWellness
4. Frost & Sullivan Recognizes ValveXchanges Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages
5. Almost 30% of Long-Term Care is Financed Out-of-Pocket, Report Finds
6. Prudential Long-Term Care Product Simplifies Decisions
7. Long-term outlook good for rotator cuff repairs
8. Goserelin improves long-term survival in premenopausal women with early breast cancer
9. Infection prevention falls short in Canadian long-term care facilities
10. Location, Location, Location: Cost of Long-Term Care Services Vary Widely by Region
11. BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials

Post Your Comments:

(Date:12/7/2009)... estimate their 2009 tax return by using the free tax calculator. Answer simple ... ... 2009 -- Taxpayers can estimate their 2009 tax return by using the free ... a child could understand it. No more waiting or worrying about how much ... a handy tool everyone can use., , , Find out right now ...

(Date:12/7/2009)... more emotional and behavioral difficulties when compared to other ... most when a parent is deployed overseas, according to ... having a parent deployed for a longer period of ... with emotional problems were important factors associated with whether ... published online by the journal Pediatrics . , ...

(Date:12/6/2009)... Calif., Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... a Phase I/II study showing safety and clinical ... Lymphoma (NHL) treated with its HDAC inhibitor PCI-24781 ... today at the 51st ASH Annual Meeting being ... ,, PCI-24781 is an oral pan-HDAC inhibitor ...

(Date:12/6/2009)... treatments targeting growth factor, researchers say , , SUNDAY, ... cancer cells from the main tumor to other parts ... known as TGFb, which may prove a promising target ... researchers say. , Previous studies have shown that TGFb ... movement. In this new study, a team from Cancer ...

(Date:12/6/2009)... 6 Sickle cell disease, a condition ... is one of the most common genetic blood ... including more than 70,000 Americans.(1) Research presented today ... Society of Hematology highlights intriguing studies on the ... children with this blood disorder, evaluations of both ...

[1] 2009 Free Tax Return Calculator [0] Military children face more emotional challenges as parental deployments grow longer, study finds [1] Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting [1] Breast Cancer's Spread Now Better Understood [0] Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease

... having a tough time with jail inmates who are poking ... , with ex- beau Rick Salomon. ,A fellow ... saying 'Paris sure knows how to do hard time, we've ... said that prisoners were constantly taunting a sobbing Hilton by ...

... even at the cost of lives, are turning out to ... are far less likely than whites to get specialized ... leave them more vulnerable to future fatal attacks. ... American Medical Association, tracked 1.2 million Medicare patients at least ...

... has helped thousands of disabled worldwide to walk again, is ... foreign soil . ,The Colombian government has sanctioned the ... limb, to set up base in the South American country. ... NGO. ,M.K. Mathur of BMVSS told IANS: "The ...

... shown a significant increase in Northern Ireland since the early ... living in more affluent areas . The study also revealed ... disease. ,Researchers, who looked at official cancer statistics ... 20 per cent increase in patients and a 62 per ...

... that what I "thought" to be a cold was a bronchial ... could wind up in the hospital . But then a good ... because I have life insurance, only I just can't afford to ... the over inflated prices of medical care and prescription medications. I ...

... emphasised the safety and efficacy of Enbrel (etanercept) in ... ,Biologics, such as etanercept, work by blocking ... body called tumour necrosis factor that is involved in ... as an anti-TNF therapy, etanercept has shown to halt ...

Other Medicine News:Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2 Health News:Jaipur Foot All Set to Launch Its Centre in Columbia 2 Health News:Deadly Skin Cancer Bites the Rich Harder 2 Health News:Deadly Skin Cancer Bites the Rich Harder 3 Health News:Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore 2 Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2

Paris' Sex Tape Comes Back to Haunt Her in the Slammer Racial Discrimination Takes The Nobility Out Of Doctoring Jaipur Foot All Set to Launch Its Centre in Columbia Deadly Skin Cancer Bites the Rich Harder Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis

(Date:12/4/2009)... Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. ... of the American Red Cross are hard at work ... they endure that could potentially put Philadelphia,s blood supply ... strike and set up a picket line yesterday when ...

(Date:12/4/2009)... Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... teleconference and webcast. Principal investigators will discuss the ... myeloma, as featured at the 51st American Society of ... at 9:00 a.m. CT/10:00 a.m. ET on Monday, December ...

(Date:12/4/2009)... CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ... to provide therapy equipment and rehab supplies to Benchmark ... Georgia. ,, "We are pleased to be named ... K. Beardall, executive vice president of sales and marketing ...

Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2 Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2 U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 1 U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 2 U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 3 U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 4 DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1 DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2 DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3 DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4 SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 1 SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 2 SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 3 SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 4

[0] Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions [0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy

... NicOx S.A.,(Euronext Paris: COX) today announced its financial ... during the year. NicOx also,announced today the initiation of ... (see separate press release)., Key highlights 2007:, ... 3 trials for naproxcinod (the ...

... ROCKVILLE, Md., Feb. 29 A study ... genetic variation in the,Ciliary Neurotrophic Factor gene ... study, conducted by Vanda Pharmaceuticals,Inc., included patients ... either with Fiapta(TM) (iloperidone), a novel atypical,antipsychotic ...

Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)

Shoulder rasp...

Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...

... allows braided suture to be used in ... may be used with any type or ... with anchors or screws (including suture pre-assembled ... Relay can be passed through any conventional ...

Medicine Products:

Shoulder Instability Rasp BirdBeak Suture Passer, Right, 45 Handle BirdBeak Suture Passer, 22 Up Tip Shuttle Relay™ Suture Passer

Long-term L-carnitine supplementation prevents development of li...( A study will be published on March 2...),Health